169 related articles for article (PubMed ID: 36849939)
1. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia.
Mo J; Deng L; Peng K; Ouyang S; Ding W; Lou L; Lin Z; Zhu J; Li J; Zhang Q; Wang P; Wen Y; Chen X; Yue P; Lu JJ; Zhu K; Zheng Y; Wang Y; Zhang X
J Hematol Oncol; 2023 Feb; 16(1):15. PubMed ID: 36849939
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value.
Pagliuca S; Gurnari C; Zhang K; Kewan T; Bahaj W; Mori M; Nautiyal I; Rubio MT; Ferraro F; Maciejewski JP; Wang L; Visconte V
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499220
[TBL] [Abstract][Full Text] [Related]
3. VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.
Wang L; Jia B; Claxton DF; Ehmann WC; Rybka WB; Mineishi S; Naik S; Khawaja MR; Sivik J; Han J; Hohl RJ; Zheng H
Oncoimmunology; 2018; 7(9):e1469594. PubMed ID: 30228937
[TBL] [Abstract][Full Text] [Related]
4. Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
Zhang Q; Hossain DM; Duttagupta P; Moreira D; Zhao X; Won H; Buettner R; Nechaev S; Majka M; Zhang B; Cai Q; Swiderski P; Kuo YH; Forman S; Marcucci G; Kortylewski M
Blood; 2016 Mar; 127(13):1687-700. PubMed ID: 26796361
[TBL] [Abstract][Full Text] [Related]
5. VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms.
Zhang K; Zakeri A; Alban T; Dong J; Ta HM; Zalavadia AH; Branicky A; Zhao H; Juric I; Husich H; Parthasarathy PB; Rupani A; Drazba JA; Chakraborty AA; Ching-Cheng Huang S; Chan T; Avril S; Wang LL
Cell Rep; 2024 Jan; 43(1):113661. PubMed ID: 38175754
[TBL] [Abstract][Full Text] [Related]
6. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
[TBL] [Abstract][Full Text] [Related]
7. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
Thakkar D; Paliwal S; Dharmadhikari B; Guan S; Liu L; Kar S; Tulsian NK; Gruber JJ; DiMascio L; Paszkiewicz KH; Ingram PJ; D Boyd-Kirkup J
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131861
[TBL] [Abstract][Full Text] [Related]
8. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.
Redell MS; Ruiz MJ; Alonzo TA; Gerbing RB; Tweardy DJ
Blood; 2011 May; 117(21):5701-9. PubMed ID: 21447830
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.
Jiang X; Hu C; Ferchen K; Nie J; Cui X; Chen CH; Cheng L; Zuo Z; Seibel W; He C; Tang Y; Skibbe JR; Wunderlich M; Reinhold WC; Dong L; Shen C; Arnovitz S; Ulrich B; Lu J; Weng H; Su R; Huang H; Wang Y; Li C; Qin X; Mulloy JC; Zheng Y; Diao J; Jin J; Li C; Liu PP; He C; Chen Y; Chen J
Nat Commun; 2017 Dec; 8(1):2099. PubMed ID: 29235481
[TBL] [Abstract][Full Text] [Related]
10. Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma.
Wu L; Deng WW; Huang CF; Bu LL; Yu GT; Mao L; Zhang WF; Liu B; Sun ZJ
Cancer Immunol Immunother; 2017 May; 66(5):627-636. PubMed ID: 28236118
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Combined with Thalidomide Reduces Expression of
Mohammadi Kian M; Salemi M; Bahadoran M; Haghi A; Dashti N; Mohammadi S; Rostami S; Chahardouli B; Babakhani D; Nikbakht M
Drug Des Devel Ther; 2020; 14():185-194. PubMed ID: 32021103
[TBL] [Abstract][Full Text] [Related]
12. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
[TBL] [Abstract][Full Text] [Related]
13. Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction.
Mostböck S; Wu HH; Fenn T; Riegler B; Strahlhofer S; Huang Y; Hansen G; Kroe-Barrett R; Tirapu I; Vogt AB
Front Immunol; 2022; 13():862757. PubMed ID: 35967294
[TBL] [Abstract][Full Text] [Related]
14. Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.
Qin H; Yang L; Chukinas JA; Shah N; Tarun S; Pouzolles M; Chien CD; Niswander LM; Welch AR; Taylor N; Tasian SK; Fry TJ
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531250
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Deng J; Li J; Sarde A; Lines JL; Lee YC; Qian DC; Pechenick DA; Manivanh R; Le Mercier I; Lowrey CH; Varn FS; Cheng C; Leib DA; Noelle RJ; Mabaera R
Cancer Immunol Res; 2019 Jul; 7(7):1079-1090. PubMed ID: 31088847
[TBL] [Abstract][Full Text] [Related]
16. PD-1H/VISTA mediates immune evasion in acute myeloid leukemia.
Kim TK; Han X; Hu Q; Vandsemb EN; Fielder CM; Hong J; Kim KW; Mason EF; Plowman RS; Wang J; Wang Q; Zhang JP; Badri T; Sanmamed MF; Zheng L; Zhang T; Alawa J; Lee SW; Zeidan AM; Halene S; Pillai MM; Chandhok NS; Lu J; Xu ML; Gore SD; Chen L
J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38060328
[TBL] [Abstract][Full Text] [Related]
17. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A
Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells.
Zhao J; Xu Y; Zong Y; Zhang S; Song Y; Yu K; Li Z; Ji Y; Qiu Y; Chen F
Hematology; 2011 Jul; 16(4):232-5. PubMed ID: 21756540
[TBL] [Abstract][Full Text] [Related]
19. LAPTM4B promotes AML progression through regulating RPS9/STAT3 axis.
Huang Y; Peng M; Qin H; Li Y; Pei L; Liu X; Zhao X
Cell Signal; 2023 Jun; 106():110623. PubMed ID: 36758682
[TBL] [Abstract][Full Text] [Related]
20. Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling.
Kang SH; Jeong SJ; Kim SH; Kim JH; Jung JH; Koh W; Kim JH; Kim DK; Chen CY; Kim SH
PLoS One; 2012; 7(4):e28706. PubMed ID: 22493659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
